Effects of Atorvastatin on Resting and Peak Exercise Blood Pressure among Normotensive Men and Women
Table 1
Baseline subjects characteristics (mean ± SEM) among the total sample and by atorvastatin and placebo groups by sex.
Variable
Total sample ()
Atorvastatin ()
Placebo ()
Men ()
Women ()
Men (
Women ()
Age (yr)
44.1 ± 0.8
43.5 ± 1.6
43.3 ± 1.6
43.6 ± 1.5
45.6 ± 1.6
BMI (kg·m−2)
26.4 ± 0.2
27.4 ± 0.4
27.4 ± 0.4
LDL (mg·dL−1)
117.4 ± 1.6
121.3 ± 3.1
116.6 ± 3.9
118.6 ± 2.8
113.5 ± 3.2
Total cholesterol (mg·dL−1)
196.6 ± 1.9
196.5 ± 3.3
200.7 ± 4.4
191.6 ± 3.2
197.7 ± 3.8
HDL (mg·dL−1)
58.1 ± 0.8
49.9 ± 1.4
65.0 ± 1.6†
50.6 ± 1.1
66.0 ± 1.7†
Triglycerides (mg·dL−1)
106.6 ± 2.7
126.0 ± 6.3
95.6 ± 4.1†
112.3 ± 6.2
94.6 ± 4.3†
VO2peak (mL·kg−1·min−1)
33.9 ± 0.5
38.6 ± 0.9
30.9 ± 0.9†
37.8 ± 0.9
29.0 ± 0.8†
Blood pressure medication use
BMI, body mass index; HDL, high density lipoprotein; LDL, low density lipoprotein; HR, heart rate; VO2peak, peak oxygen consumption. , , and †; men versus women.
